EX-99.1 2 d822582dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Village Farms International, Inc.

Condensed Consolidated Interim Financial Statements

Three and Nine Months Ended September 30, 2019 and 2018

(Unaudited)


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Financial Position

(In thousands of United States dollars)

(Unaudited)

 

     September 30, 2019     December 31, 2018  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 6,726     $ 11,920  

Trade receivables

     9,970       11,292  

Amounts due from joint ventures (note 7)

     10,690       10,873  

Other receivables

     265       332  

Inventories (note 4)

     16,201       22,485  

Biological asset (note 5)

     4,414       4,230  

Prepaid expenses and deposits

     1,892       889  
  

 

 

   

 

 

 

Total current assets

     50,158       62,021  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment (note 6)

     67,965       77,479  

Due from joint ventures (note 7)

     9,500       —    

Right-of-use assets (note 3)

     3,733       —    

Investment in joint ventures (note 7)

     55,026       18,108  

Other assets

     1,768       2,207  
  

 

 

   

 

 

 

Total assets

   $ 188,150     $ 159,815  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Line of credit

   $ 4,000     $ 2,000  

Trade payables

     9,270       14,601  

Current maturities of long-term debt (note 8)

     3,424       3,414  

Accrued liabilities

     6,320       3,509  

Lease liabilities - current (note 3)

     927       78  
  

 

 

   

 

 

 

Total current liabilities

     23,941       23,602  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt (note 8)

     29,911       32,445  

Deferred tax liability

     210       1,920  

Lease liabilities (note 3)

     2,973       102  

Other liabilities

     1,237       1,050  
  

 

 

   

 

 

 

Total liabilities

     58,272       59,119  
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Share capital

     76,484       60,872  

Contributed surplus

     4,216       2,198  

Revaluation surplus (note 6)

     3,351       4,321  

Accumulated other comprehensive loss

     (504     (562

Retained earnings

     46,331       33,867  
  

 

 

   

 

 

 

Total shareholders’ equity

     129,878       100,696  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 188,150     $ 159,815  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

1


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity

(In thousands of United States dollars, except for shares outstanding)

(Unaudited)

 

     Number of
Common
Shares
     Share
Capital
     Contributed
Surplus
    Revaluation
Surplus
    Accumulated Other
Comprehensive
(Loss) Income
    Retained
Earnings
    Total
Shareholders’
Equity
 

Balance at January 1, 2018 (restated - note 3)

     42,242,612      $ 36,115      $ 1,726     $ 4,321     $ (391   $ 39,012     $ 80,783  

Shares issued on exercise of stock options

     354,400        275        —         —         —         —         275  

Shares issued pursuant to private placement of common shares, net of issuance costs

     1,886,793        7,755        —         —         —         —         7,755  

Share-based compensation (note 16)

     —          —          447       —         —         —         447  

Cumulative translation adjustment

     —          —          —         —         (48     —         (48

Net loss

     —          —          —         —         —         (5,415     (5,415
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at September 30, 2018

     44,483,805      $ 44,145      $ 2,173     $ 4,321     $ (439   $ 33,597     $ 83,797  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at January 1, 2019

     47,642,672      $ 60,872      $ 2,198     $ 4,321     $ (562   $ 33,867     $ 100,696  

Shares issued on exercise of stock options

     83,998        224        (116     —         —         —         108  

Share-based compensation (note 16)

     313,665        908        2,282       —         —         —         3,190  

Shares issued on exercise of warrants

     300,000        614        (148     —         —         —         466  

Shares issued pursuant to public offering of common shares, net of issuance costs (note 16)

     1,000,000        13,866        —         —         —         —         13,866  

Cumulative translation adjustment

     —          —          —         —         58       —         58  

Reclassification of previously recorded revaluation gain of land (note 6)

     —          —          —         (970     —         —         (970

Net income

     —          —          —         —         —         12,464       12,464  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at September 30, 2019

     49,340,335      $ 76,484      $ 4,216     $ 3,351     $ (504   $ 46,331     $ 129,878  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

2


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss)

(In thousands of United States dollars, except per share data)

(Unaudited)

 

     Three Months Ended September 30,     Nine Months Ended September 30,  
     2019     2018     2019     2018  

Sales (note 14)

   $ 38,293     $ 39,684     $ 111,512     $ 111,213  

Cost of sales (note 11)

     (38,866     (36,862     (114,711     (103,915

Change in biological asset (note 5)

     (627     (1,189     (97     (992

Selling, general and administrative expenses (note 11)

     (4,607     (3,632     (14,872     (10,933
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (5,807     (1,999     (18,168     (4,627

Interest expense

     (697     (709     (2,154     (2,017

Interest income

     304       91       651       111  

Foreign exchange (loss) gain

     (183     (73     338       (87

Other income, net

     69       17       219       61  

Share of income (loss) from joint ventures (note 7)

     (171     (28     17,939       (369

(Loss) gain on disposal of assets (note 7)

     (8     —         13,558       —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

     (6,493     (2,701     12,383       (6,928

Recovery of income taxes

     1,421       712       81       1,513  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (5,072   $ (1,989   $ 12,464     $ (5,415
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic income (loss) per share (note 15)

   $ (0.10   $ (0.04   $ 0.26     $ (0.12
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted income (loss) per share (note 15)

   $ (0.10   $ (0.04   $ 0.25     $ (0.12
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss) :

        

Foreign currency translation adjustment

     (22     40       58       (48
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income (loss)

   $ (5,094   $ (1,949   $ 12,522     $ (5,463
  

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

3


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Cash Flows

(In thousands of United States dollars)

(Unaudited)

 

     Nine Months Ended
September 30,
 
     2019     2018  

Cash flows used in operating activities:

    

Net income (loss)

   $ 12,464     $ (5,415

Adjustments to reconcile net income (loss) to net cash used in operating activities:

    

Depreciation and amortization

     5,587       5,271  

Share of (income) loss from joint ventures (note 7)

     (17,939     369  

Interest expense

     2,154       2,017  

Interest income

     (651     (111

Gain on disposal of assets (note 7)

     (13,558     —    

Share-based compensation (note 16)

     3,190       447  

Deferred income taxes

     (840     (2,301

Change in biological asset (note 5)

     97       992  

Changes in non-cash working capital items (note 13)

     4,375       (4,493
  

 

 

   

 

 

 

Net cash used in operating activities

     (5,121     (3,224
  

 

 

   

 

 

 

Cash flows used in investing activities:

    

Purchases of property, plant and equipment, net of rebate

     (2,251     (2,546

Note receivables to joint ventures (note 7)

     (9,302     (6,781

Proceeds from sale of asset

     52       —    

Investment in joint ventures (note 7)

     (332     —    
  

 

 

   

 

 

 

Net cash used in investing activities

     (11,833     (9,327
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from borrowings

     3,000       7,000  

Repayments on borrowings

     (3,591     (1,766

Interest paid on long-term debt, net

     (1,455     (1,906

Proceeds from issuance of common stock pursuant to public offering, net

     13,868       7,755  

Proceeds from exercise of stock options

     109       275  

Payments on capital lease obligations

     (637     (45

Proceeds from exercise of warrants

     466       —    
  

 

 

   

 

 

 

Net cash provided by financing activities

     11,760       11,313  
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     —         (2
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (5,194     (1,240

Cash and cash equivalents, beginning of period

     11,920       7,091  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 6,726     $ 5,851  
  

 

 

   

 

 

 

Supplemental cash flow information:

    

Income taxes paid

   $ 575     $ —    
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

4


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

1

NATURE OF OPERATIONS

Village Farms International, Inc. (“VFF” the parent company, together with its subsidiaries, the “Company”) is incorporated under the Canada Business Corporation Act. VFF’s principal operating subsidiaries as at September 30, 2019 are Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”), and VF Clean Energy, Inc. (“VFCE”). The address of the registered office of VFF is 4700 80th Street, Delta, British Columbia, Canada, V4K 3N3. VFF owns a 65% equity interest in Village Fields Hemp USA LLC (“VF Hemp”), a 60% equity interest in Arkansas Valley Green and Gold Hemp (“AVGG Hemp) and a 50% equity interest in Pure Sunfarms Corp. (“Pure Sunfarms”), all of which are recorded as Investments in Joint Ventures (note 7).

The Company’s shares are listed on the Toronto Stock Exchange under the symbol VFF and are also listed in the United States on the Nasdaq Capital Market (“Nasdaq”) under the symbol VFF.

The Company owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. The Company also markets and sells third party produce through its subsidiaries. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant that generates electricity. The Company’s joint venture, Pure Sunfarms, is a licensed producer and supplier of cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. The Company’s joint ventures, VF Hemp and AVGG Hemp, are cultivators and extractors of high cannabidiol (“CBD”) hemp in multiple states throughout the United States.

 

2

BASIS OF PRESENTATION

Statement of Compliance

The Company’s unaudited condensed consolidated interim financial statements (“interim financial statements”) have been prepared in accordance with International Financial Reporting Standards (“IFRS”) and its interpretations, as issued by the International Accounting Standards Board (“IASB”), as applicable to interim financial statements, including International Accounting Standard (“IAS”) 34, Interim Financial Reporting. They do not include all of the information required for full annual financial statement disclosures and should be read in conjunction with the Company’s audited annual consolidated financial statements for the year ended December 31, 2018, which were prepared in accordance with IFRS.

Basis of Presentation

The interim financial statements are prepared on a going concern basis. The accounting policies have been applied consistently in all material respects. These interim financial statements have been prepared by applying the same accounting policies, assessments of estimates and judgments, and methods of computation as compared with the most recent annual consolidated financial statements with the exception of IFRS 16, Leases as described in Note 3.

Basis of Measurement

The interim financial statements have been prepared on the historical cost basis except for the following material items in the condensed consolidated interim statement of financial position (“interim statement of financial position”):

 

   

biological assets are measured at fair value less costs to sell;

 

   

land is valued at fair market value; and

 

   

marketable equity securities are measured at fair value through profit and loss.

Functional and Presentation Currency

The functional currency for each entity included in these interim financial statements is the currency of the primary economic environment in which the entity operates. These interim financial statements are presented in United States dollars (“U.S. dollars”) which have been rounded to the nearest thousands, except per share amounts. Currency conversion to U.S. dollars is performed in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates.

 

 

5


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

3

CHANGES IN ACCOUNTING POLICIES

These changes were made in accordance with the applicable transitional provisions.

Amendments to IFRS 11, Joint Arrangements, and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each statement of financial position date, the Company will consider whether there is objective evidence that its investment in the joint venture is impaired. If there is such evidence of impairment, the Company will determine the amount of the impairment and a loss will be recorded in the condensed consolidated interim statement of income (loss) (“interim statement of income (loss)”). The adoption of the amendments to IFRS 11 did not have and impact on the Company’s interim financial statements.

IFRS 16, Leases, was issued in January 2016 to replace IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, i.e. the customer (lessee) and the supplier (lessor) to increase transparency and comparability among organizations by requiring the recognition of right-of-use assets and lease liabilities on the balance sheet.

On January 1, 2019, the Company adopted IFRS 16 using the updated modified retrospective transition approach and did not restate prior periods. The Company’s classes of assets include land leases, building leases and equipment leases.

On adoption, the Company recognized lease liabilities in relation to leases which had previously been classified as ‘operating leases’ under the principles of IAS 17, Leases. These lease liabilities were measured at the present value of the remaining lease payments, discounted using the borrowing rate of the Company. The weighted average incremental borrowing rate applied to the lease liabilities on January 1, 2019 was 6.25%. These leases are included in right-of-use assets, short-term lease liabilities and long-term lease liabilities in the consolidated balance sheet. Right-of-use assets are amortized on a straight-line basis over the lease term.

For leases previously classified as finance leases the entity recognized the carrying amount of the lease asset and lease liability immediately before transition as the carrying amount of the right of use asset and the lease liability at the date of initial application.

Additionally, the Company has elected the short-term lease exception for all classes of assets, and does not apply the recognition requirements for leases of 12 months or less, and recognizes lease payments for short-term leases as expense either straight-line over the lease term or as incurred depending on whether the lease payments are fixed or variable. These elections are applied consistently for all leases.

 

     2019  

Operating lease commitments disclosed as at December 31, 2018

   $  5,064  

Less: short-term leases recognized on a straight-line basis as expense

     (210
  

 

 

 
     4,854  

Discounted using the lessee’s incremental borrowing rate of 6.25% at the date of initial application

     4,269  

Add: additional leases identified on adoption of IFRS 16

     88  

Add: finance lease liabilities recognized as at December 31, 2018

     180  
  

 

 

 

Lease liability recognized as at January 1, 2019

   $ 4,537  

Of which are:

  

Current lease liabilities

     1,022  

Non-current lease liabilities

     3,515  
  

 

 

 
   $ 4,537  
  

 

 

 

 

6


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

The recognized right-of-use assets relate to the following types of assets:

 

     December 31, 2018      January 1, 2019  

Land

   $  —        $ 140  

Building

     —          4,017  

Equipment

     176        380  
  

 

 

    

 

 

 

Total right-of-use assets

   $ 176      $  4,537  
  

 

 

    

 

 

 

 

4

INVENTORIES

 

     September 30, 2019      December 31, 2018  

Deferred crop costs

   $  18,839      $  24,649  

Purchased produce inventory

     425        643  

Biological asset adjustment (note 5)

     (3,153      (2,871

Spare parts inventory

     90        64  
  

 

 

    

 

 

 
   $ 16,201      $ 22,485  
  

 

 

    

 

 

 

The cost of inventories recognized as expense and included in cost of sales for the three months ended September 30, 2019 amounted to $32,179 (2018 - $30,769) and $95,060 for the nine months ended September 30, 2019 (2018 - $85,349). The biological asset adjustment reclassifies actual costs incurred for the biological asset from inventories to biological asset on the interim statements of financial position.

 

5

BIOLOGICAL ASSET

Information about the biological asset presented on the interim statements of financial position and in the interim statements of income (loss) is as follows:

 

     September 30,
2019
     December 31,
2018
     September 30,
2018
 

Estimated sales value - biological asset

   $  9,078      $  8,004      $  10,550  

Less

        

Estimated remaining costs to complete

     4,174        3,304        4,862  

Estimated selling costs

     490        470        569  
  

 

 

    

 

 

    

 

 

 

Fair value of biological asset less costs to sell

     4,414        4,230        5,119  

Less actual costs

     3,152        2,871        3,918  
  

 

 

    

 

 

    

 

 

 

Increase in fair value of biological asset over cost

     1,262        1,359        1,201  

Fair value over cost of harvested and sold biological asset - beginning of year

     1,359        2,193        2,193  
  

 

 

    

 

 

    

 

 

 

Change in biological asset

   $ (97    $ (834    $ (992
  

 

 

    

 

 

    

 

 

 

 

7


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

6

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consist of the following:

 

     Land     Leasehold
and land
improve-
ments
    Buildings     Machinery
and
Equipment
    Construction
in process
    Total  

At January 1, 2019

            

Cost

   $ 9,047     $ 3,820     $ 77,003     $ 65,664     $ 552     $  156,086  

Accumulated depreciation

     —         (2,308     (36,289     (40,186     —         (78,783
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value (note 3)

   $ 9,047     $ 1,512     $ 40,714     $ 25,478     $ 552     $ 77,303  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nine Months ended September 30, 2019

            

Opening net book value

   $ 9,047     $ 1,512     $ 40,714     $ 25,478     $ 552     $ 77,303  

Additions/transfers

     —         —         297       741       1,086       2,124  

Placed in service

     —         —         —         —         (430     (430

Disposals

     (1,848     —         (4,552     (4,178     —         (10,578

Accum deprec on disposal

     —         —         1,934       2,305       —         4,239  

Depreciation expense

     —         (64     (1,716     (3,010     —         (4,790

Foreign currency translation adjustment

     —         —         8       89       —         97  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Closing net book value

   $ 7,199     $ 1,448     $ 36,685     $ 21,425     $ 1,208     $ 67,965  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At September 30, 2019

            

Cost

   $ 7,199     $ 3,820     $ 72,747     $ 61,646     $ 1,208     $ 146,620  

Accumulated depreciation

     —         (2,372     (36,062     (40,221     —         (78,655
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

   $ 7,199     $ 1,448     $ 36,685     $ 21,425     $  1,208     $ 67,965  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Depreciation related to the greenhouse facilities and equipment is expensed in cost of sales. Land is the only item of property, plant and equipment that is stated at fair values. On March 31, 2019, Pure Sunfarms exercised its option to acquire the Delta 2 assets and operations. Delta 2 land was disposed of as part of that transaction (note 7). The revaluation surplus related to Delta 2 of $1.0 million, net of taxes, that was previously recorded as a component of equity, was reclassified and included as part of the gain on disposal of assets recorded in the interim statements of income (loss).

 

7

INVESTMENT IN JOINT VENTURES

Pure Sunfarms Corp.

On June 6, 2017, the Company entered into an agreement to form Pure Sunfarms, a B.C. corporation, with Emerald Health Therapeutics Inc. (“Emerald”). The purpose of Pure Sunfarms is to produce, market and distribute cannabis in Canada. Village Farms has a 50% ownership interest in Pure Sunfarms in the form of common shares. The Company has concluded that the agreement constitutes a joint arrangement where joint control is shared with Emerald and therefore has accounted for Pure Sunfarms in accordance with IFRS 11 and IAS 28, using the equity method.

On July 5, 2018, the Company and Emerald Health Therapeutics Canada Inc. (a subsidiary of Emerald) (together, the “Shareholders”) entered into a Shareholder Loan Agreement (the “Loan Agreement”) with Pure Sunfarms, whereby, as at September 30, 2019, the Shareholders had each contributed $9,959 (CA$13,000) in the form of a demand loan to Pure Sunfarms. Effective January 1, 2019, the loan amounts bear simple interest at the rate of 6.2% per annum, calculated semi-annually. Interest will accrue and be payable upon demand being made by both Shareholders (see note 10).

On March 31, 2019, Pure Sunfarms exercised its option to utilize the Delta 2 assets and operations. The contribution of the assets has been accounted for as a disposal of the land, greenhouse facility and other assets in exchange for 25,000,000 common shares of Pure Sunfarms. This was a non-cash transaction, and it was estimated that the fair value of the land, building and other assets was $18.7 million (CA$25 million) at the date of contribution. The Company recognized a gain of $13.6 million on the contribution of the fixed assets. The Company had previously recorded a fair value increase on the Delta 2 land being contributed (2016 - $2.0 million), which was recorded in accumulated other comprehensive income, net of taxes of $1.0 million. As a result

 

8


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

of the contribution of the Delta 2 land, this amount has been recycled to the interim statements of income, and has been included in the gain noted above. As at September 30, 2019, the total investment in Pure Sunfarms of US$54.2 million is recorded in the interim statements of financial position. Final determination with respect to the transfer of the land, building and equipment will not be made until year end. As such, the investment and related gain on disposal of assets may be adjusted at year end.

Pursuant to the terms of a Supply Agreement that Pure Sunfarms has with Emerald, Emerald has a right to purchase 40% of Pure Sunfarms cannabis production at a fixed price, subject to the terms and conditions of the Supply Agreement. To the extent that Emerald does not fulfill its purchase obligation, Pure Sunfarms is able to sell that excess production to other parties in the open market. The Supply Agreement stipulates that Emerald is required to pay Pure Sunfarms the difference between the fixed price and the selling price realized from other parties. During the quarter ended September 30, 2019, Emerald did not fulfill its purchase obligation and Pure Sunfarms sold the product on the open market to arm’s length parties at prices lower than the fixed price in the Supply Agreement. As a result, under the terms of the Supply Agreement, Pure Sunfarms invoiced Emerald for the difference which amounted to approximately CA$7.2 million. On October 15, 2019, Emerald issued a press release that indicated they do not agree that they have any liability with respect to these amounts.

Under IFRS 15, Revenue from Contracts with Customers (paragraph 9 (e)), a customer needs to have an intent and ability to pay in order for a company to recognize revenue. Given that Emerald has issued a press release indicating that they do not agree that they have a liability with respect to these amounts, Pure Sunfarms has determined that all of the criteria under IFRS 15 to recognize this revenue were not met as Emerald has demonstrated that they do not have an intent to pay, and as a result has not recorded the revenue related to these amounts.

The Company’s share of the joint venture consists of the following (in $000’s of USD):

 

Balance, January 1, 2019

   $  18,108  

Investments in joint venture

     18,661  

Transaction costs

     55  

Share of net income for the period

     17,342  
  

 

 

 

Balance, September 30, 2019

   $ 54,166  
  

 

 

 

Summarized financial information of Pure Sunfarms (in $000’s of CAD):

 

     September 30, 2019      December 31, 2018  

Current assets

     

Cash and cash equivalents (including restricted cash)

   $ 16,128      $ 2,362  

Trade receivables

     22,977        1,312  

Inventory

     15,141        8,356  

FV of biological asset in inventory

     12,053        —    

Biological asset

     11,757        7,388  

Other current assets

     6,584        996  

Non-current assets

     119,963        67,263  

Current liabilities

     

Trade payables

     (4,827      (9,361

Borrowings due to joint venture partners

     (27,563      (26,523

Other current liabilities

     (20,014      (3,582

Non-current liabilities

     

Borrowings – long term

     (17,500      —    

Deferred tax liability

     (2,979      (2,688
  

 

 

    

 

 

 

Net assets

   $  131,720      $ 45,523  
  

 

 

    

 

 

 

 

9


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

Summarized financial information of Pure Sunfarms (in $000’s of CAD):

 

     September 30, 2019      December 31, 2018  

Reconciliation of net assets:

     

Accumulated retained earnings

   $ 51,730      $ 5,523  

Contributions from joint venture partners

     79,990        40,000  
  

 

 

    

 

 

 

Net assets

   $  131,720      $  45,523  
  

 

 

    

 

 

 

Summarized financial information of Pure Sunfarms (in $000’s of CAD):

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2019      2018      2019      2018  
  

 

 

    

 

 

    

 

 

    

 

 

 

Revenue

   $ 23,953      $ 247      $ 70,668      $ 247  
Cost of sales*      (7,536      (186      (17,906      (186
Selling, general and administrative expenses      (3,742      (792      (7,454      (2,107
Realized FV included in inventory sold      (31,700      —          (59,124      —    
Change in fair value of bio-asset      19,071        697        74,149        1,119  
  

 

 

    

 

 

    

 

 

    

 

 

 
Income (loss) from operations      46        (34      60,333        (927
Interest expense      (399      —          (789      —    
Foreign exchange gain (loss)      19        (40      37        (12
Other income, net      11        —          29        —    
  

 

 

    

 

 

    

 

 

    

 

 

 
Income (loss) before taxes      (323      (74      59,610        (939
Provision for income taxes      (2,105      —          (13,404      —    
  

 

 

    

 

 

    

 

 

    

 

 

 
Net income (loss)    $  (2,428    $  (74    $ 46,206      $ (939
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

Included in cost of sales for the three and nine months ended September 30, 2019 is CA$654 and CA$1,777 of amortization expense.

 

     Three months ended
September 30, 2019
     Nine months ended
September 30, 2019
 

Cash provided by operating activities

   $ 3,521      $ 9,899  
Cash used in investing activities    $  (11,985    $  (29,717

Cash provided by financing activities

   $ 5,943      $ 33,585  

Village Fields Hemp USA LLC

On February 27, 2019, the Company entered into a joint venture with Nature Crisp, LLC (“Nature Crisp”) to form VF Hemp for the objective of outdoor cultivation of high percentage cannabidiol (“CBD”) hemp and CBD extraction in multiple states throughout the United States. VF Hemp is 65% owned by the Company and 35% owned by Nature Crisp. Under the terms of the VF Hemp Joint Venture Agreement, the Company will lend approximately US$15 million to VF Hemp for start-up costs and working capital. Capital investment for extraction capabilities is to be determined and dependent on future decisions with respect to the locations of hemp production and the extraction operations. The Company has concluded that the agreement constitutes a joint arrangement where joint control is shared with Nature Crisp and therefore has accounted for VF Hemp in accordance with IFRS 11 and IAS 28, using the equity method.

On March 25, 2019, the Company entered into a Grid Loan Agreement (the “Grid Loan”) with VF Hemp, whereby, as at September 30, 2019, the Company had advanced $8,315 in the form of a grid loan to VF Hemp. The Grid Loan has a maturity date of March 25, 2022, and bears simple interest at the rate of 8% per annum, calculated monthly (note 10).

 

10


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

The Company’s share of the joint venture consists of the following:

 

Balance, beginning of the period

   $  —    

Investments in joint venture

     7  

Share of net income

     632  

Transaction costs

     219  
  

 

 

 

Balance, September 30, 2019

   $ 858  
  

 

 

 

Summarized financial information of VF Hemp:

 

     September 30, 2019  

Current assets

  

Cash and cash equivalents

   $ 111  

Inventory

     198  

Prepaid expenses and deposits

     177  

Biological asset

     7,889  

Non-current assets

     1,267  

Current liabilities

     (3

Borrowings due to joint venture partner

     (8,315

Other non-current liabilities

     (342
  

 

 

 

Net assets

   $ 982  
  

 

 

 

 

     September 30, 2019  

Reconciliation of net assets:

  

Net income for the nine months ended September 30, 2019

   $  972  

Contributions from joint venture partners

     10  
  

 

 

 

Net assets

   $ 982  
  

 

 

 

 

     Three months ended
September 30, 2019
     Nine months ended
September 30, 2019
 

Change in fair value of the biological asset

     2,030        2,030  

General and administrative expenses

     (314      (504

Interest expense

     (134      (209

Share of loss from JV

     —          (3

Provision for income taxes

     (405      (342
  

 

 

    

 

 

 

Net income

   $  1,177      $ 972  
  

 

 

    

 

 

 

Arkansas Valley Green and Gold Hemp

On May 21, 2019, the Company entered into a joint venture with Arkansas Valley Hemp, LLC (“AV Hemp”) for the objective of outdoor cultivation of high percentage cannabidiol (CBD) hemp and CBD extraction in Colorado. The joint venture, AVGG Hemp, is 60% owned by the Company, 35% owned by AV Hemp, and 5% owned by VF Hemp.

Under the terms of the AVGG Hemp Joint Venture Agreement, the Company will lend approximately US$5 million to AVGG Hemp for start-up costs and working capital. The loans bear simple interest at the rate of 8% per annum, calculated monthly (note 10). To the extent cash is available from positive cash flow, the AVGG Hemp has agreed to repay the Company with respect to any such loans, in the range of $2 million to $5 million in the initial two years following the formation of AVGG Hemp. As at September 30, 2019, the Company had loaned AVGG Hemp approximately $1,185 (note 10).

 

11


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

The Company has concluded that the agreement constitutes a joint arrangement where joint control is shared with AV Hemp and therefore has accounted for AVGG Hemp in accordance with IFRS 11 and IAS 28, using the equity method.

The Company is not legally obligated for the debts, obligations or liabilities of AVGG Hemp.

The Company’s share of the joint venture consists of the following:

 

Balance, beginning of the period

   $  —    

Investments in joint venture

     6  

Share of net loss

     (35

Transaction costs

     31  
  

 

 

 

Balance, September 30, 2019

   $ 2  
  

 

 

 

Summarized financial information of AVGG Hemp:

 

     September 30, 2019  

Current assets

  

Cash and cash equivalents

   $ 39  

Inventory

     40  

Biological asset

     696  

Non-current assets

     362  

Borrowings due to joint venture partner

     (1,185
  

 

 

 

Net assets

   $ (48
  

 

 

 
Reconciliation of net assets:   

Net loss for the nine months ended September 30, 2019

   $ (58

Contributions from joint venture partners

     10  
  

 

 

 

Net assets

   $ (48
  

 

 

 

Summarized joint ventures’ information:

 

     Investment in joint ventures
at September 30, 2019
 

Pure Sunfarms

   $ 54,166  

VF Hemp

     858  

AVGG Hemp

     2  
  

 

 

 

Total

   $ 55,026  
  

 

 

 

 

     Share of income (loss) from joint ventures  
     Three months ended September 30,      Nine months ended September 30,  
     2019      2018      2019      2018  

Pure Sunfarms

   $ (918    $ (28    $ 17,342      $ (369

VF Hemp

     765        —          632        —    

AVGG Hemp

     (18      —          (35      —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ (171    $ (28    $ 17,939      $ (369
  

 

 

    

 

 

    

 

 

    

 

 

 

 

12


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

     Amounts due from joint ventures  
     September 30, 2019      December 31, 2018  
     Short term      Long term      Short term      Long term  

Pure Sunfarms

   $ 10,690      $ —        $ 10,873      $ —    

VF Hemp

     —          8,315        —          —    

AVGG Hemp

     —          1,185        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 10,690      $ 9,500      $ 10,873      $ —    
  

 

 

    

 

 

    

 

 

    

 

 

 

 

8

DEBT

 

     September 30, 2019      December 31, 2018  

Long-term debt:

     

Opening balance

   $ 35,859      $ 38,380  

IFRS 9 adjustment for deferred financing fees

     —          260  

Repayment of debt

     (2,640      (2,738

Foreign currency translation

     116        (43
  

 

 

    

 

 

 

Closing balance

   $ 33,335      $ 35,859  
  

 

 

    

 

 

 

Current portion

   $ 3,424      $ 3,414  

Non-current portion

     29,911        32,445  
  

 

 

    

 

 

 
   $ 33,335      $ 35,859  
  

 

 

    

 

 

 

The Company’s subsidiary has two loan agreements in place with a Canadian Chartered bank. As at September 30, 2019, the balance on the non-revolving fixed rate loan was US$1,117 (December 31, 2018 – US$1,279) and the balance on the uncommitted credit facility for capital expenditures was US$113 (December 31, 2018 – US$138).

The Company has a line of credit agreement with a Canadian Chartered Bank (“Operating Loan”). The revolving Operating Loan has a line of credit up to CA$13,000 and variable interest rates with a maturity date on May 31, 2021 and is subject to margin requirements stipulated by the bank. As at September 30, 2019, US$4,000 was drawn on this facility (December 31, 2018 – US$2,000), which is available to a maximum of CA$13,000, less outstanding letters of credit totaling US$150 and CA$38.

The Company’s borrowings (“Credit Facilities”) are subject to certain positive and negative covenants. As at September 30, 2019 the Company was in compliance with all covenants on its Credit Facilities.

Accrued interest payable on the credit facilities and loans as at September 30, 2019 was $171 (December 31, 2018 – $184) and these amounts are included in accrued liabilities in the interim statement of financial position.

As security for the FCC Loan, the Company has provided promissory notes, a first mortgage on the VFF-owned greenhouse properties (excluding the Delta 3 and Delta 2 greenhouse facilities), and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as at September 30, 2019 was $154,402 (December 31, 2018 – $114,554).

As security for the Operating Loan, the Company has provided promissory notes and a first priority security interest over its accounts receivable and inventory. In addition, the Company has granted full recourse guarantees and security therein. The carrying value of the assets pledged as collateral as at September 30, 2019 was $30,585 (December 31, 2018 – $38,007).

The aggregate annual principal maturities of long-term debt for the next five years and thereafter are as follows:

 

Remainder of 2019

   $ 857  

2020

     3,409  

2021

     28,551  

2022

     340  

2023

     178  

Thereafter

     —    
  

 

 

 
   $ 33,335  
  

 

 

 

 

13


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

9

FINANCIAL INSTRUMENTS

As at September 30, 2019 and December 31, 2018, the Company’s financial instruments included cash and cash equivalents, trade receivables, notes receivable, other receivables, patronage stock, accounts payable, other current liabilities and notes payable. Due to the short-term maturities of cash and cash equivalents, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate fair value at the respective statement of financial position dates. The carrying value of the notes receivable and notes payable approximate their fair value based on a comparison with the prevailing market interest rates. The fair values of the Company’s notes receivable and notes payable are level 2 measurements in the fair value hierarchy. All other financial assets and liabilities are level 1.

There were no financial instruments categorized as Level 3 as at September 30, 2019 and December 31, 2018. There were no transfers of assets or liabilities between levels during the three and nine months ended September 30, 2019 and December 31, 2018, respectively.

Interest income, interest expense and gains and losses from loans, receivables and other financial liabilities are recognized in the interim statements of income (loss). The following table summarizes interest income and expense for the three and nine months ended September 30:

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2019      2018      2019      2018  

Interest income earned on cash and cash equivalents

   $ —        $ 12      $ 25      $ 15  

Interest income earned on other financial assets

   $ 304      $ —        $ 626      $ —    

Interest expense from other financial liabilities

   $ 697      $ 635      $ 2,154      $ 1,921  

Management of financial risks

The Company, through its financial assets and liabilities, is exposed to various risks. The following provides a measurement of some of these risks as at September 30, 2019 and December 31, 2018. The Company uses financial instruments only for risk management purposes, not for generating trading profit.

 

  i)

Credit risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade receivables, other receivables and amounts due from joint ventures. The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had one customer that represented more than 10% of the balance of trade receivables, representing 11.1% of the balance of trade receivables as at September 30, 2019 (December 31, 2018 – two customer represented 13.8% and 11.5%). The Company believes that its expected credit losses are limited due to the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its sales in the United States, which represent the majority of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables of the debtor).

As at September 30, 2019, the allowance for doubtful accounts balance was calculated based on the expected credit loss model and expected credit losses continues to be insignificant.

As at September 30, 2019, 98.1% (December 31, 2018 – 90.3%) of trade receivables were outstanding less than 30 days, 0.9% (December 31, 2018 – 8.3%) were outstanding for between 30 and 90 days and the remaining 1.0% (December 31, 2018 – 1.4%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

 

  ii)

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt, for which the interest rates charged fluctuate based on the 90-day LIBOR rate. If interest rates had been 50 basis points higher, the net income during the nine months ended September 30, 2019 would have been lower by $84. This represents $84 in increased interest expense (2018 – $138).

 

14


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

  iii)

Foreign exchange risk

As at September 30, 2019, the Canadian/U.S. foreign exchange rate was CA$1.00 = US$0.7552 (December 31, 2018 – US$0.7336). Assuming that all other variables remain constant, an increase of $0.10 in the Canadian dollar would have the following impact on the ending balances of certain interim statements of financial position items at September 30, 2019 and December 31, 2018 with the net foreign exchange gain or loss directly impacting net income (loss).

 

     September 30, 2019      December 31, 2018  

Financial assets

     

Cash and cash equivalents

   $ 189      $ 839  

Trade receivables

     367        328  

JV notes receivable

     1,387        1,335  

Financial liabilities

     

Trade payables and accrued liabilities

     (658      (373

Loan payable

     (163      (193
  

 

 

    

 

 

 

Net foreign exchange gain (loss)

   $ 1,122      $ 1,936  
  

 

 

    

 

 

 

 

  iv)

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they fall due. The following are the contractual maturities of financial liabilities as at September 30, 2019:

 

Financial liabilities

   Total      1 year      2-3 years      4-5 years      More than 5 years  

Long-term debt

   $ 35,604      $ 3,688      $ 31,699      $ 217      $ —    

Line of credit

     4,000        4,000        —          —          —    

Trade payables

     9,270        9,270        —          —          —    

Accrued liabilities

     6,320        6,320        —          —          —    

Lease liabilities

     4,618        1,149        2,226        1,243        —    

Other liabilities

     1,237        —          1,237        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 61,049      $ 24,427      $ 35,162      $ 1,460      $ —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash from sales. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing. In addition, as at September 30, 2019, the Company has an operating credit facility of up to CA$13,000, of which US$4,000 was drawn as at September 30, 2019, less outstanding letters of credit totaling US$150 and CA$38.

 

10

RELATED PARTY TRANSACTIONS AND BALANCES

On February 13, 2019, the Company announced that Pure Sunfarms had entered into a credit agreement with Bank of Montreal, as agent and lead lender, and Farm Credit Canada, as lender, in respect of a CA$20 million secured non-revolver term loan (the “Credit Facility”). The Credit Facility, which matures on February 7, 2022, is secured by the Delta 3 facility, and contains customary financial and restrictive covenants. The Company is not a party to the Credit Facility but has provided a limited guarantee in the amount of CA$10 million in connection with the Credit Facility.

As at September 30, 2019, the Company had amounts due from its joint venture, Pure Sunfarms, totaling $218 (December 31, 2018—$1,079) primarily for consulting services. These amounts are non-interest bearing and due on demand. On July 5, 2018, the Shareholders entered into a Loan Agreement in the form of a demand loan to Pure Sunfarms. As at September 30, 2019, the balance Pure Sunfarms owed the Company, including interest was $10,472. These amounts are included in amounts due from joint venture in the interim statements of financial position (note 7).

 

15


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

On March 25, 2019, the Company entered into a Grid Loan Agreement (the “Grid Loan”) with VF Hemp, whereby, as at September 30, 2019, the Company had contributed $8,315 in the form a grid loan to VF Hemp. The Grid Loan has a maturity date of March 25, 2022, and bears simple interest at the rate of 8% per annum, calculated monthly.

Under the terms of the AVGG Hemp Joint Venture Agreement, the Company will lend approximately US$5 million to AVGG Hemp for start-up costs and working capital. The loan bears simple interest at the rate of 8% per annum, calculated monthly (note 7). As at September 30, 2019, the Company had loaned AVGG Hemp approximately $1,185 (note 7).

One of the Company’s employees is related to a member of the Company’s executive management team and received approximately $81 in salary and benefits during the nine months ended September 30, 2019 (2018 – $81).

Included in accrued expenses and other current liabilities is $50 paid to the Company by an employee for taxes incurred on a stock option exercise. The Company paid the taxes in October 2019.

Included in other assets as at December 31, 2018 is a $64 promissory note that represents the unpaid amount the Company advanced to an employee in connection with a relocation at the request of the Company. The promissory note was paid in full June 10, 2019.

 

11

EXPENSES BY NATURE

The following table outlines the Company’s significant expenses by nature:

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
Cost of sales    2019      2018      2019      2018  

Purchased produce

   $ 12,253      $ 13,104      $ 36,954      $ 32,871  

Raw materials and consumables used

     11,324        6,979        31,402        23,244  

Depreciation and amortization

     1,794        1,720        5,506        5,185  

Transportation and storage

     5,169        5,024        16,158        15,465  

Employee compensation and benefits

     8,326        10,035        24,691        27,150  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 38,866      $ 36,862      $ 114,711      $ 103,915  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended
September 30,
     Nine months ended
September 30,
 
Selling, general and administrative expenses    2019      2018      2019      2018  

Employee benefits – salaries and short-term benefits

   $ 2,896      $ 2,393      $ 9,390      $ 6,857  

Marketing

     115        79        168        257  

Professional services

     704        437        2,690        1,507  

Office expenses

     460        408        1,326        1,299  

Other

     432        315        1,298        1,013  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 4,607      $ 3,632      $ 14,872      $ 10,933  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended
September 30,
     Nine months ended
September 30,
 
Employee compensation and benefits    2019      2018      2019      2018  

Salaries and short-term employee benefits

   $ 10,354      $ 12,238      $ 30,891      $ 33,560  

Share-based compensation

     868        190        3,190        447  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 11,222      $ 12,428      $ 34,081      $ 34,007  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

16


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

12

INCOME TAX

Income tax expense is recognized based on management’s best estimate of the weighted average annual income tax rate expected for the full financial year. The estimated average annual rate used for the nine months ended September 30, 2019 was 24%, excluding the change in biological asset as reported on the interim statements of income (loss), and 25% for the nine months ended September 30, 2018.

 

13

CHANGES IN NON-CASH WORKING CAPITAL ITEMS

 

     Nine months ended September 30,  
     2019      2018  

Trade receivables

   $ 1,327      $ 132  

Inventories

     6,078        (3,324

Inventories reclassified to biological asset

     (74      (1,715

Prepaid expenses and other current assets

     (936      700  

Trade payables

     (5,322      (2,413

Accrued liabilities and taxes

     1,881        2,144  

Other assets/other liabilities, net

     1,421        (17
  

 

 

    

 

 

 
   $ 4,375      $ (4,493
  

 

 

    

 

 

 

 

14

SEGMENT AND GEOGRAPHIC INFORMATION

The Company’s two reporting segments include the Produce business and the Energy business. The Produce business produces, markets, and sells the product group which consists of premium quality tomatoes, bell peppers and cucumbers. The Energy business produces power that it sells per a long-term contract to its one customer. The Company’s Chief Operating Decision Maker also reviews the results of the Company’s three joint ventures on a quarterly basis (note 7).

The Company’s primary operations are in the United States and Canada. Net sales by the countries in which its customers are located are as follows:

 

     Three months ended September 30,      Nine months ended September 30,  
     2019      2018      2019      2018  

Net Sales

           

United States

   $ 30,734      $ 32,073      $ 92,594      $ 92,391  

Canada

     7,072        7,139        17,874        17,371  

Energy – Canada

     487        472        1,044        1,451  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 38,293      $ 39,684      $ 111,512      $ 111,213  
  

 

 

    

 

 

    

 

 

    

 

 

 

The Company’s property, plant and equipment, net of accumulated depreciation, and right-of-use assets are located as follows:

 

     September 30, 2019      December 31, 2018  

United States

   $ 42,051      $ 43,651  

Canada

     23,027        30,459  

Energy - Canada

     2,887        3,369  
  

 

 

    

 

 

 
   $ 67,965      $ 77,479  
  

 

 

    

 

 

 

Depreciation and amortization charges in the Produce business for the three and nine months ended September 30, 2019 were $1,591 (2018 - $1,515) and $5,011 (2018 - $4,627), respectively. Depreciation and amortization charges in the Energy business for the three and nine months ended September 30, 2019 were $230 (2018 - $233) and $576 (2018 - $644), respectively.

 

17


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

15

INCOME PER SHARE

Basic income per share is calculated by dividing the net income attributable to owners of the Company by the weighted average number of common shares in issue during the year excluding common shares purchased by the Company and held as treasury shares.

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2019      2018      2019      2018  

Net (loss) income attributable to owners of the Company

   $ (5,072    $ (1,989    $ 12,464      $ (5,415

Weighted average number of common shares outstanding (thousands)

     48,845        44,475        48,650        44,473  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic (loss) income per share

   $ (0.10    $ (0.04    $ 0.26      $ (0.12
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted income per share is calculated by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company’s share options are potentially dilutive to common shares. A calculation is done to determine the number of shares that could have been acquired at fair value (determined as the average market share price of the Company’s shares for the year) based on the monetary value of the subscription rights attached to outstanding share options. The number of shares calculated above is compared with the number of shares that would have been issued assuming the exercise of the share options. If dilutive effect is less than zero, then issuance is anti-dilutive and is excluded from dilutive income per share calculation.

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2019      2018      2019      2018  

Net income (loss) attributable to owners of the Company

   $ (5,072    $ (1,989    $ 12,464      $ (5,415

Weighted average number of common shares outstanding (thousands)

     48,845        44,475        48,650        44,473  

Adjustment for:

           

Share options (thousands)

     —          —          1,801        —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average number of common shares outstanding for diluted earnings per share (thousands)

     48,845        44,475        50,451        44,473  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted (loss) income per share

   $ (0.10    $ (0.04    $ 0.25      $ (0.12
  

 

 

    

 

 

    

 

 

    

 

 

 

For the three and nine months ended September 30, 2019, there were options to purchase 310,000 shares of the Company’s common stock that were excluded from the diluted income per share computation because the impact of the assumed exercise of such stock options would have been anti-dilutive during the respective periods. For the three and nine months ended September 30, 2018, there were no options excluded from the diluted income per share computation because the impact of the assumed exercise of such stock options would have been anti-dilutive.

 

16

SHAREHOLDERS’ EQUITY

In April 2019, the Company completed a bought deal offering of 1,000,000 common shares of the Company at an offering price of CA$20.00 per offered share for net aggregate proceeds to the Company of approximately CA$18,700 after deducting offering fees of CA$1,300.

The Company has a share-based compensation plan. The maximum number of common shares that can be issued upon the exercise of options granted is equal to 10% of the aggregate number of common shares issued and outstanding from time to time. The term during which an option may be exercised is 10 years from the date of the grant. Options generally vest at a rate of 33% per year, beginning one year following the grant date of the options. Share-based compensation expense for the three months and nine months ended September 30, 2019 of $867 (2018 - $190) and $3,190 (2018 - $447), respectively, was recorded in selling, general and administrative expenses and the corresponding amount credited to contributed surplus.

 

18


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2019 and 2018

(In thousands of United States dollars, except share and per share amounts, unless otherwise noted)

 

During the nine months ended September 30, 2019, 355,000 performance-based restricted share units were granted to Village Farms employees and directors involved with future developments of the Company. Once a performance target is met and the share units are deemed earned and vested, compensation expense based on the fair value of the share units on the grant date is recorded in selling, general and administrative expenses in the interim statements of income. There were 1,093,000 performance-based restricted share units outstanding as at September 30, 2019, of which 934,000 were not vested as at September 30, 2019.

 

17

REPORTING REQUIREMENTS

Effective January 1, 2020, the Company intends to comply with Securities and Exchange Commission reporting requirements applicable to U.S. domestic issuers. This will also require the Company’s financial statements and financial data to be presented under U.S. generally accepted accounting principles (“US GAAP”). Accordingly, the Company will file its annual report on Form 10-K for the year ended December 31, 2019 under US GAAP, and regular periodic reports under both Canadian and U.S. law thereafter under US GAAP.

 

18

SUBSEQUENT EVENTS

On October 22, 2019, the Company completed a bought deal offering of 3,059,000 common shares of the Company at an offering price of CA$9.40 per offered share for net aggregate proceeds to the Company of approximately CA$26,934 after deducting offering fees of CA$1,821.

 

19